Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans

Human Molecular Genetics

Volumn 24, Issue 19, 2015, Pages 5589-5602

  Al Olama, Ali Amin ^a   Dadaev, Tokhir ^d   Hazelett, Dennis J ^e,f   Li, Qiuyan ^g   Leongamornlert, Daniel ^d   Saunders, Edward J ^d   Stephens, Sarah ^d   Cieza Borrella, Clara ^d   Whitmore, Ian ^d   Garcia, Sara Benlloch ^a   Giles, Graham G ^h,i   Southey, Melissa C ^j   Fitzgerald, Liesel ^k   Gronberg, Henrik ^l   Wiklund, Fredrik ^l   Aly, Markus ^l,m   Henderson, Brian E ^f   Schumacher, Fredrick ^f   Haiman, Christopher A ^f   Schleutker, Johanna ^n,o   Wahlfors, Tiina ^o   Tammela, Teuvo L ^p   Nordestgaard, Børge G ^q,r   Key, Tim J ^s   Travis, Ruth C ^s   Neal, David E ^b,u   Donovan, Jenny L ^v   Hamdy, Freddie C ^s,t   Pharoah, Paul ^a   Pashayan, Nora ^a,w   Khaw, Kay Tee ^c   Stanford, Janet L ^x,y   Thibodeau, Stephen N ^z   Mcdonnell, Shannon K ^z   Schaid, Daniel J ^z   Maier, Christiane ^aa   Vogel, Walther ^ab   Luedeke, Manuel ^aa   Herkommer, Kathleen ^ac   Kibel, Adam S ^ad   Cybulski, Cezary ^ae   Wokolorczyk, Dominika ^ae   Kluzniak, Wojciech ^ae   Cannon Albright, Lisa ^af,ag   Brenner, Hermann ^ah   Butterbach, Katja ^ah   Arndt, Volker ^ah   Park, Jong Y ^e   Sellers, Thomas ^e   Lin, Hui Yi ^ai   Slavov, Chavdar ^aj   Kaneva, Radka ^ak   Mitev, Vanio ^ak   Batra, Jyotsna ^al   Clements, Judith A ^al   Spurdle, Amanda ^am   Teixeira, Manuel R ^an,ao   Paulo, Paula ^an   Maia, Sofia ^an   Pandha, Hardev ^ap   Michael, Agnieszka ^ap   Kierzek, Andrzej ^ap   Govindasami, Koveela ^d   Guy, Michelle ^d   Lophatonanon, Artitaya ^aq,ar   Muir, Kenneth ^aq,ar   Viñuela, Ana ^as   Brown, Andrew A ^at,au   Freedman, Mathew ^av   Conti, David V ^e,f   Easton, Douglas ^a   Coetzee, Gerhard A ^e,f   Eeles, Rosalind A ^d   Kote Jarai, Zsofia ^d   more..

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^e The Institute of Cancer Research and Royal Marsden NHS Foundation Trust ^*  (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^g XIAMEN UNIVERSITY   (China)

^h CANCER EPIDEMIOLOGY CENTRE   (Australia)

ⁱ UNIVERSITY OF MELBOURNE   (Australia)

^j UNIVERSITY OF MELBOURNE   (Australia)

^k Tissupath Pty Ltd   (Australia)

^l KAROLINSKA INSTITUTE   (Sweden)

^m DANDERYD HOSPITAL   (Sweden)

ⁿ UNIVERSITY OF TURKU   (Finland)

^o TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^p TAMPERE UNIVERSITY HOSPITAL   (Finland)

^q GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^r UNIVERSITY OF COPENHAGEN   (Denmark)

^s UNIVERSITY OF OXFORD   (United Kingdom)

^t UNIVERSITY OF OXFORD   (United Kingdom)

^u CANCER RESEARCH UK CAMBRIDGE RESEARCH INSTITUTE   (United Kingdom)

^v UNIVERSITY OF BRISTOL   (United Kingdom)

^w UNIVERSITY COLLEGE LONDON   (United Kingdom)

^x Fred Hutchinson Cancer Research Center   (United States)

^y UNIVERSITY OF WASHINGTON   (United States)

^z MAYO CLINIC   (United States)

^aa UNIVERSITY HOSPITAL ULM   (Germany)

^ab UNIVERSITY OF ULM   (Germany)

^ac TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^ad BRIGHAM AND WOMEN S HOSPITAL   (United States)

^ae POMERANIAN MEDICAL UNIVERSITY   (Poland)

^af UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^ag VETERANS AFFAIRS MEDICAL CENTER   (United States)

^ah GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^ai H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^aj UNIVERSITY HOSPITAL ALEXANDROVSKA   (Bulgaria)

^ak MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^al QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^am QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^an PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^ao UNIVERSITY OF PORTO   (Portugal)

^ap UNIVERSITY OF SURREY   (United Kingdom)

^aq UNIVERSITY OF MANCHESTER   (United Kingdom)

^ar UNIVERSITY OF WARWICK   (United Kingdom)

^as KING'S COLLEGE LONDON   (United Kingdom)

^at UNIVERSITY OF OSLO   (Norway)

^au UNIVERSITY OF GENEVA   (Switzerland)

^av DANA FARBER CANCER INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; ANOCTAMIN 7; CHROMOSOME 10 OPEN READING FRAME 32 PROTEIN; DEOXYRIBONUCLEASE I; HEPATOCYTE NUCLEAR FACTOR 1BETA; MATRILYSIN; MEMBRANE PROTEIN; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PROTEIN; TRANSMEMBRANE PROTEIN 180; TUBULIN TYROSINE LIGASE LIKE FAMILY MEMBER 12; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER GROWTH; CANCER RISK; CANCER SUSCEPTIBILITY; CELL PROLIFERATION; CELL SURVIVAL; CHINESE; CONTROLLED STUDY; EAST ASIAN; ENHANCER REGION; ETHNIC DIFFERENCE; EUROPEAN; FOLLOW UP; GENE CONTROL; GENE EXPRESSION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE MAPPING; GENE STRUCTURE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HEREDITY; HERITABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRON; LNCAP CELL LINE; MALE; METASTASIS; PDLIM5 GENE; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; CAUCASIAN; CHROMOSOMAL MAPPING; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; PROCEDURES; PROSTATE TUMOR;

CHROMOSOME MAPPING; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS;

EID: 84943753608     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddv203     Document Type: Article

References (62)

1. Hjelmborg, J.B., Scheike, T., Holst, K., Skytthe, A., Penney, K.L., Graff, R.E., Pukkala, E., Christensen, K., Adami, H.O., Holm, N.V. et al. (2014) The heritability of prostate cancer in the Nordic Twin Study of Cancer. Cancer Epidemiol. Biomarkers Prev., 23, 2303-2312.
2. Leongamornlert, D., Saunders, E., Dadaev, T., Tymrakiewicz, M., Goh, C., Jugurnauth-Little, S., Kozarewa, I., Fenwick, K., Assiotis, I., Barrowdale, D. et al. (2014) Frequent germline deleterious mutations in DNA repair genes in familial prostate cancer cases are associated with advanced disease. Br. J. Cancer, 110, 1663-1672.
3. Ewing, C.M., Ray, A.M., Lange, E.M., Zuhlke, K.A., Robbins, C.M., Tembe, W.D., Wiley, K.E., Isaacs, S.D., Johng, D., Wang, Y. et al. (2012) Germline mutations in HOXB13 and prostatecancer risk. N. Engl. J. Med., 366, 141-149.
4. Al Olama, A.A., Kote-Jarai, Z., Berndt, S.I., Conti, D.V., Schumacher, F., Han, Y., Benlloch, S., Hazelett, D.J.,Wang, Z., Saunders, E. et al. (2014) A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer. Nat. Genet., 46, 1103-1109.
5. Kote-Jarai, Z., Amin Al Olama, A., Leongamornlert, D., Tymrakiewicz, M., Saunders, E., Guy, M., Giles, G.G., Severi, G., Southey, M., Hopper, J.L. et al. (2011) Identification of a novel prostate cancer susceptibility variant in the KLK3 gene transcript. Hum. Genet., 129, 687-694.
6. Kote-Jarai, Z., Saunders, E.J., Leongamornlert, D.A., Tymrakiewicz, M., Dadaev, T., Jugurnauth-Little, S., Ross-Adams, H., Al Olama, A.A., Benlloch, S., Halim, S. et al. (2013) Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression. Hum. Mol. Genet., 22, 2520-2528.
7. Al Olama, A.A., Kote-Jarai, Z., Giles, G.G., Guy, M., Morrison, J., Severi, G., Leongamornlert, D.A., Tymrakiewicz, M., Jhavar, S., Saunders, E. et al. (2009) Multiple loci on 8q24 associated with prostate cancer susceptibility. Nat. Genet., 41, 1058-1060.
8. Akamatsu, S., Takata, R., Haiman, C.A., Takahashi, A., Inoue, T., Kubo, M., Furihata, M., Kamatani, N., Inazawa, J., Chen, G.K. et al. (2012) Common variants at 11q12, 10q26 and 3p11.2 are associated with prostate cancer susceptibility in Japanese. Nat. Genet., 44, 426-429. S421.
9. Takata, R., Akamatsu, S., Kubo, M., Takahashi, A., Hosono, N., Kawaguchi, T., Tsunoda, T., Inazawa, J., Kamatani, N., Ogawa, O. et al. (2010) Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population. Nat. Genet., 42, 751-754.
10. Xu, J., Mo, Z., Ye, D.,Wang, M., Liu, F., Jin, G., Xu, C.,Wang, X., Shao, Q., Chen, Z. et al. (2012) Genome-wide association study in Chinese men identifies two newprostate cancer risk loci at 9q31.2 and 19q13.4. Nat. Genet., 44, 1231-1235.
11. Duggan, D., Zheng, S.L., Knowlton, M., Benitez, D., Dimitrov, L., Wiklund, F., Robbins, C., Isaacs, S.D., Cheng, Y., Li, G. et al. (2007) Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP. J. Natl. Cancer Inst., 99, 1836-1844.
12. Eeles, R.A., Olama, A.A., Benlloch, S., Saunders, E.J., Leongamornlert, D.A., Tymrakiewicz, M., Ghoussaini, M., Luccarini, C., Dennis, J., Jugurnauth-Little, S. et al. (2013) Identification of 23 newprostate cancer susceptibility loci using the iCOGS customgenotyping array. Nat. Genet., 45, 385-391, 391e381-382.
13. Kote-Jarai, Z., Olama, A.A., Giles, G.G., Severi, G., Schleutker, J., Weischer, M., Campa, D., Riboli, E., Key, T., Gronberg, H. et al. (2011) Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nat. Genet., 43, 785-791.
14. Hazelett, D.J., Rhie, S.K., Gaddis, M., Yan, C., Lakeland, D.L., Coetzee, S.G., Ellipse/GAME-ON Consortium, Practical Consortium, Henderson, B.E., Noushmehr, H., Cozen, W., Kote-Jarai, Z. et al. (2014) Comprehensive functional annotation of 77 prostate cancer risk loci. PLoS Genet., 10, e1004102.
15. Cai, C., He, H.H., Chen, S., Coleman, I., Wang, H., Fang, Z., Chen, S., Nelson, P.S., Liu, X.S., Brown, M. et al. (2011) Androgen receptor gene expression in prostate cancer is directly suppressed by the androgen receptor through recruitment of lysine-specific demethylase 1. Cancer Cell, 20, 457-471.
16. Eeles, R.A., Kote-Jarai, Z., Giles, G.G., Olama, A.A., Guy, M., Jugurnauth, S.K., Mulholland, S., Leongamornlert, D.A., Edwards, S.M., Morrison, J. et al. (2008) Multiple newly identified loci associated with prostate cancer susceptibility. Nat. Genet., 40, 316-321.
17. Eeles, R.A., Kote-Jarai, Z., Al Olama, A.A., Giles, G.G., Guy, M., Severi, G., Muir, K., Hopper, J.L., Henderson, B.E., Haiman, C.A. et al. (2009) Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nat. Genet., 41, 1116-1121.
18. Chung, C.C., Ciampa, J., Yeager, M., Jacobs, K.B., Berndt, S.I., Hayes, R.B., Gonzalez-Bosquet, J., Kraft, P., Wacholder, S., Orr, N. et al. (2011) Fine mapping of a region of chromosome 11q13 reveals multiple independent loci associated with risk of prostate cancer. Hum. Mol. Genet., 20, 2869-2878.
19. Sun, J., Zheng, S.L.,Wiklund, F., Isaacs, S.D., Purcell, L.D., Gao, Z., Hsu, F.C., Kim, S.T., Liu,W., Zhu, Y. et al. (2008) Evidence for two independent prostate cancer risk-associated loci in the HNF1B gene at 17q12. Nat. Genet., 40, 1153-1155.
20. Gudmundsson, J., Sulem, P., Gudbjartsson, D.F., Blondal, T., Gylfason, A., Agnarsson, B.A., Benediktsdottir, K.R., Magnusdottir, D.N., Orlygsdottir, G., Jakobsdottir, M. et al. (2009) Genome- wide association and replication studies identify four variants associated with prostate cancer susceptibility. Nat. Genet., 41, 1122-1126.
21. Amoroso, F., Falzoni, S., Adinolfi, E., Ferrari, D. and Di Virgilio, F. (2012) The P2X7 receptor is a key modulator of aerobic glycolysis. Cell Death Dis., 3, e370.
22. Hitosugi, T., Fan, J., Chung, T.W., Lythgoe, K.,Wang, X., Xie, J., Ge, Q., Gu, T.L., Polakiewicz, R.D., Roesel, J.L. et al. (2011) Tyrosine phosphorylation of mitochondrial pyruvate dehydrogenase kinase 1 is important for cancer metabolism. Mol. Cell, 44, 864-877.
23. Bera, T.K., Das, S., Maeda, H., Beers, R.,Wolfgang, C.D., Kumar, V., Hahn, Y., Lee, B. and Pastan, I. (2004) NGEP, a gene encoding a membrane protein detected only in prostate cancer and normal prostate. Proc. Natl. Acad. Sci. USA, 101, 3059-3064.
24. Das, S., Hahn, Y., Walker, D.A., Nagata, S., Willingham, M.C., Peehl, D.M., Bera, T.K., Lee, B. and Pastan, I. (2008) Topology of NGEP, a prostate-specific cell:cell junction protein widely expressed in many cancers of different grade level. Cancer Res., 68, 6306-6312.
25. Mohsenzadegan, M., Madjd, Z., Asgari, M., Abolhasani, M., Shekarabi, M., Taeb, J. and Shariftabrizi, A. (2013) Reduced expression of NGEP is associated with high-grade prostate cancers: a tissue microarray analysis. Cancer Immunol. Immunother., 62, 1609-1618.
26. Golmard, L., Caux-Moncoutier, V., Davy, G., Al Ageeli, E., Poirot, B., Tirapo, C., Michaux, D., Barbaroux, C., d'Enghien, C.D., Nicolas, A. et al. (2013) Germline mutation in the RAD51B gene confers predisposition to breast cancer. BMC Cancer, 13, 484.
27. Orr, N., Lemnrau, A., Cooke, R., Fletcher, O., Tomczyk, K., Jones, M., Johnson, N., Lord, C.J., Mitsopoulos, C., Zvelebil, M. et al. (2012) Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk. Nat. Genet., 44, 1182-1184.
28. Harries, L.W., Perry, J.R., McCullagh, P. and Crundwell, M. (2010) Alterations in LMTK2, MSMB and HNF1B gene expression are associated with the development of prostate cancer. BMC Cancer, 10, 315.
29. Xu,X., Hussain,W.M., Vijai, J., Offit, K., Rubin,M.A.,Demichelis, F. and Klein, R.J. (2014) Variants at IRX4 as prostate cancer expression quantitative trait loci. Eur. J. Hum. Genet., 22, 558-563.
30. Li, Q., Stram, A., Chen, C., Kar, S., Gayther, S., Pharoah, P., Haiman, C., Stranger, B., Kraft, P. and Freedman, M.L. (2014) Expression QTL-based analyses reveal candidate causal genes andlociacrossfivetumor types. Hum.Mol.Genet.,23,5294-5302.
31. Penney, K.L., Sinnott, J.A., Tyekucheva, S., Gerke, T., Shui, I.M., Kraft, P., Sesso, H.D., Freedman, M.L., Loda, M., Mucci, L.A. et al. (2014) Association of prostate cancer risk variants with gene expression in normal and tumor tissue. Cancer Epidemiol. Biomarkers Prev., 24, 255-262.
32. Buil, A., Brown, A.A., Lappalainen, T., Vinuela, A., Davies, M.N., Zheng, H.F., Richards, J.B., Glass, D., Small, K.S., Durbin, R. et al. (2014) Gene-gene and gene-environment interactions detected by transcriptome sequence analysis in twins. Nat. Genet., 47, 88-91.
33. Brown, A.A., Buil, A., Vinuela, A., Lappalainen, T., Zheng, H.F., Richards, J.B., Small, K.S., Spector, T.D., Dermitzakis, E.T. and Durbin, R. (2014) Genetic interactions affecting human gene expression identified by variance association mapping. Elife, 3, e01381.
34. Wasylyk, C., Zambrano, A., Zhao, C., Brants, J., Abecassis, J., Schalken, J.A., Rogatsch, H., Schaefer, G., Pycha, A., Klocker, H. et al. (2010) Tubulin tyrosine ligase like 12 links to prostate cancer through tubulin posttranslational modification and chromosome ploidy. Int. J. Cancer, 127, 2542-2553.
35. Wood, A.R., Hernandez, D.G., Nalls, M.A., Yaghootkar, H., Gibbs, J.R., Harries, L.W., Chong, S., Moore, M., Weedon, M.N., Guralnik, J.M. et al. (2011) Allelic heterogeneity and more detailed analyses of known loci explain additional phenotypic variation and reveal complex patterns of association. Hum. Mol. Genet., 20, 4082-4092.
36. Wood, A.R., Tuke, M.A., Nalls, M.A., Hernandez, D.G., Bandinelli, S., Singleton, A.B., Melzer, D., Ferrucci, L., Frayling, T.M. andWeedon, M.N. (2014) Another explanation for apparent epistasis. Nature, 514, E3-E5.
37. Saunders, E.J., Dadaev, T., Leongamornlert, D.A., Jugurnauth-Little, S., Tymrakiewicz, M.,Wiklund, F., Al Olama, A.A., Benlloch, S., Neal, D.E., Hamdy, F.C. et al. (2014) Fine-mapping the HOXB region detects common variants tagging a rare coding allele: evidence for synthetic association in prostate cancer. PLoS Genet., 10, e1004129.
38. Saunders, E.J., Dadaev, T., Leongamornlert, D.A., Jugurnauth-Little, S., Tymrakiewicz, M.,Wiklund, F., Al Olama, A.A., Benlloch, S., Neal, D.E., Hamdy, F.C. et al.(2013) Consortium launches genotyping effort. Cancer Discov., 3, 1321-1322.
39. Gusev, A., Bhatia, G., Zaitlen, N., Vilhjalmsson, B.J., Diogo, D., Stahl, E.A., Gregersen, P.K.,Worthington, J., Klareskog, L., Raychaudhuri, S. et al. (2013) Quantifying missing heritability at known GWAS loci. PLoS Genet., 9, e1003993.
40. Kote-Jarai, Z., Easton, D.F., Stanford, J.L., Ostrander, E.A., Schleutker, J., Ingles, S.A., Schaid, D., Thibodeau, S., Dork, T., Neal, D. et al. (2008) Multiple novel prostate cancer predisposition loci confirmed by an international study: the PRACTICAL Consortium. Cancer Epidemiol. Biomarkers Prev., 17, 2052-2061.
41. Howie, B.N., Donnelly, P. and Marchini, J. (2009) A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet., 5, e1000529.
42. Marchini, J., Howie, B., Myers, S., McVean, G. and Donnelly, P. (2007) A newmultipoint method for genome-wide association studies by imputation of genotypes. Nat. Genet., 39, 906-913.
43. Willer, C.J., Li, Y. and Abecasis, G.R. (2010) METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics, 26, 2190-2191.
44. Schaid, D.J., Rowland, C.M., Tines, D.E., Jacobson, R.M. and Poland, G.A. (2002) Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am. J. Hum. Genet., 70, 425-434.
45. Udler, M.S., Ahmed, S., Healey, C.S., Meyer, K., Struewing, J., Maranian, M., Kwon, E.M., Zhang, J., Tyrer, J., Karlins, E. et al. (2010) Fine scale mapping of the breast cancer 16q12 locus. Hum. Mol. Genet., 19, 2507-2515.
46. MacInnis, R.J., Antoniou, A.C., Eeles, R.A., Severi, G., Guy, M., McGuffog, L., Hall, A.L., O'Brien, L.T.,Wilkinson, R.A., Dearnaley, D.P. et al. (2010) Prostate cancer segregation analyses using 4390 families from UK and Australian populationbased studies. Genet. Epidemiol., 34, 42-50.
47. Macinnis, R.J., Antoniou, A.C., Eeles, R.A., Severi, G., Al Olama, A.A., McGuffog, L., Kote-Jarai, Z., Guy, M., O'Brien, L.T., Hall, A.L. et al. (2011) A risk prediction algorithm based on family history and common genetic variants: application to prostate cancer with potential clinical impact. Genet. Epidemiol., 35, 549-556.
48. Grothendieck, G. (2014) sqldf: perform SQL selects on R data frames, http://CRAN.R-project.org/package=sqldf.
49. Wickham, H. (2009) ggplot2: elegant graphics for data analysis, http://had.co.nz/ggplot2/book.
50. Yin, T., Cook, D. and Lawrence, M. (2012) ggbio: an R package for extending the grammar of graphics for genomic data. Genome Biol., 13, R77.
51. R Studio, I. (2014) Web Application Framework for R, http:// www.bioconductor.org/packages/2.11/bioc/html/ggbio.html.
52. Thurman, R.E., Rynes, E., Humbert, R., Vierstra, J., Maurano, M.T., Haugen, E., Sheffield, N.C., Stergachis, A.B., Wang, H., Vernot, B. et al. (2012) The accessible chromatin landscape of the human genome. Nature, 489, 75-82.
53. Coetzee, S.G., Rhie, S.K., Berman, B.P., Coetzee, G.A. and Noushmehr, H. (2012) FunciSNP: an R/bioconductor tool integrating functional non-coding data sets with genetic association studies to identify candidate regulatory SNPs. Nucleic Acids Res., 40, e139.
54. Wang, D., Garcia-Bassets, I., Benner, C., Li,W., Su, X., Zhou, Y., Qiu, J., Liu, W., Kaikkonen, M.U., Ohgi, K.A. et al. (2011) Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA. Nature, 474, 390-394.
55. Tan, P.Y., Chang, C.W., Chng, K.R., Wansa, K.D., Sung, W.K. and Cheung, E. (2012) Integration of regulatory networks by NKX3-1 promotes androgen-dependent prostate cancer survival. Mol. Cell. Biol., 32, 399-414.
56. Andreu-Vieyra, C., Lai, J., Berman, B.P., Frenkel, B., Jia, L., Jones, P.A. and Coetzee, G.A. (2011) Dynamic nucleosomedepleted regions at androgen receptor enhancers in the absence of ligand in prostate cancer cells. Mol. Cell. Biol., 31, 4648-4662.
57. Sharma, N.L., Massie, C.E., Ramos-Montoya, A., Zecchini, V., Scott, H.E., Lamb, A.D., MacArthur, S., Stark, R., Warren, A.Y., Mills, I.G. et al. (2013) The androgen receptor induces a distinct transcriptional program in castration-resistant prostate cancer in man. Cancer Cell, 23, 35-47.
58. Jeggari, A., Marks, D.S. and Larsson, E. (2012) miRcode: a map of putative microRNA target sites in the long non-coding transcriptome. Bioinformatics, 28, 2062-2063.
59. Wang, J., Zhuang, J., Iyer, S., Lin, X., Whitfield, T.W., Greven, M.C., Pierce, B.G., Dong, X., Kundaje, A., Cheng, Y. et al. (2012) Sequence features and chromatin structure around the genomic regions bound by 119 human transcription factors. Genome Res., 22, 1798-1812.
60. Shabalin, A.A. (2012) Matrix eQTL: ultra fast eQTL analysis via large matrix operations. Bioinformatics, 28, 1353-1358.
61. Stegle, O., Parts, L., Piipari, M., Winn, J. and Durbin, R. (2012) Using probabilistic estimation of expression residuals (PEER) to obtain increased power and interpretability of gene expression analyses. Nat. Protoc., 7, 500-507.
62. Krzywinski, M.I., Schein, J.E., Birol, I., Connors, J., Gascoyne, R., Horsman, D., Jones, S.J. and Marra, M.A. (2009) Circos: An information aesthetic for comparative genomics. Genome Res., 19, 1639-1645.